Development of Genetics in the World and in Croatia – Forty Years of the Croatian Society of Human Genetics of the Croatian Medical Association by Ljiljana Zergollern Čupak et al.
Coll. Antropol. 38 (2014) 3: 809–818
Editorial
Development of Genetics in the World and in
Croatia – Forty Years of the Croatian Society
of Human Genetics of the Croatian Medical
Association
Ljiljana Zergollern-^upak1, Ingeborg Bari{i}2 and Leona Moro`in Pohovski2
1 University of Zagreb, School of Medicine, Honorary Professor, Zagreb, Croatia
2 University of Zagreb, School of Medicine, Children’s Hospital Zagreb, Zagreb, Croatia
A B S T R A C T
Resulting from several basic scientific disciplines, genetics has made impressive progress in the last century by dis-
coveries of the heredity rules and genome structure, and by identification of the genes that determine the occurrence and
characteristics of human diseases. In Croatia, the development of genetics began in the middle of the past century by the
pioneering work of clinicians and basic scientists, which resulted in significant development of this scientific discipline
that has quickly found its practical application in clinical genetics-cytogenetics, molecular genetics and prenatal diagno-
sis. The rapid advancement of technology and knowledge of genetics in recent decades has led to the development of
genomics and related disciplines, entering the revolutionary new era of personalized medicine. Currently, much more
data can be collected than interpreted. The data of electronic medical records, genomics, epigenetics, proteomics, meta-
bolomics and microbiomics should be integrated and interpreted at the level of individual genome. Extensive use of new
information will open a range of ethical issues that we must face timely. It is expected that in the forthcoming years, we
will be able to learn more about genetics than what we have learned throughout the history of medicine. We must be pre-
pared to welcome this new knowledge, reflecting on the positive and negative aspects of the latest achievements in the
field of genetics. We hope that the experts dealing with human genetics in Croatia will successfully continue their work to
enable practical application of the latest achievements in genetics, expanding our understanding of the concept of health
and disease.
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Introduction
Resulting from several basic scientific disciplines, ge-
netics as the science of heredity and modifiable traits of
living organisms was formally recognized only in the 19th
century, based on the works of Gregor Mendel, Father of
modern genetics, who published the results of his experi-
ments with pea plants as early as 1865. Around 1900, re-
sults of these studies were confirmed by three scientists,
H. de Vries, K. Correns and E. Tschermak, independ-
ently of each other. Soon after Mendel’s observations, in
1883–1884, on cell staining during cell division E. van
Beneden detected more intensively stained and visible
structures in the cell nucleus, which he named chromo-
somes. The term genetics (Gr. genesis, origin, inception)
was first used by W. Bateson in 1905, whereas in 1909 W.
Johannsen named Mendel’s factors as genes and intro-
duced the terms genotype for the sum of all genes in an
organism and phenotype for the outer expression of the
gene determined features. In 1911, Th. H. Morgan dem-
onstrated the genes to be linearly distributed on the
chromosomes. In 1927, J. H. Muller verified that X-rays
can experimentally induce gene changes, i.e. mutations,
today known to be also inducible by many other external
factors. During more than 150 years of its existence,
Mendel’s genetics has been enriched with novel, fre-
quently quite revolutionary discoveries, while the advan-
cements in complementary sciences, in particular biolo-
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gy, chemistry, physics and mathematics, have contributed
to additional development of the genetic science and its
practical application in various fields of biologic and
medical disciplines.
Being deeply aware that life is a continuity that nei-
ther begins nor ends with us, we have been searching for
some written word, some »Yesterday«, some trace of the
initial scientific or professional interest in the role of he-
redity in our country. The idea of heredity as an essential
element of human health has been present since ancient
times in folk stories, records, beliefs, proverbs or sayings.
In Croatia, genetic science was founded by Alois Tav~ar,
agronomist. He wrote the first book on agricultural ge-
netics, entitled »Temelji nauke o nasljedstvu« (The Fun-
damentals of Heredity Science) in 1930, on the issues of
hybridization in agriculture. The roots of the profes-
sional-scientific knowledge about the role of genetics in
medicine date back to the late 1930s, in the first profes-
sional works of Boris Zarnik, Professor of Biology, and
Ernest Mayerhofer, Professor of Pediatrics at the School
of Medicine in Zagreb, tackling the then popular field of
eugenics, and the works of Stjepan Urban, Professor of
Biology from Rijeka. Several years later, Andrija [tam-
par and Ante Vuleti} from the School of Public Health in
Zagreb wrote the first papers on population genetics, and
\ur|a Mu{i}-Severova published a case report of a child
with Down syndrome as the first clinical description of a
genetic disorder in 1934.
In Croatia as well as worldwide, a true revival and
breakthrough in many sciences occurred after World War
II, with the scientists’ interest focused on the substance
of heredity, human genome in the mid-1950s. A revolu-
tionary novelty in the development of genetics was Wat-
son and Crick’s discovery of the deoxyribonucleic acid
(DNA) composition and structure in 19531. This interest
was additionally enhanced by fear from the possible un-
desired mutations caused by atomic and other types of
radiation from the bombs thrown on Hiroshima (ura-
nium) and Nagasaki (plutonium). The tragedy of the de-
stroyed Japanese towns urged and accelerated research
and search for new technologies to be used in scientific
work including human genetics. Advances and collabora-
tion of medicine and complementary sciences have re-
sulted in the advent of many novel methods such as
cytogenetic methods that facilitate identification of the
human hereditary basis and understanding of the patho-
logic conditions associated with impairments in the num-
ber and structure of chromosomes.
The beginnings of genetics as a scientific discipline re-
lated to human physiology and pathology in Croatia date
from 1959, owing to the enthusiasm and vision of Ljilja-
na Zergollern, pediatrician. In collaboration with Danilo
Tepav~evi}, endocrinologist, she issued the first cytoge-
netic finding in a human, thus confirming the revolu-
tionary discoveries by Jerome Lejeune and Charles E.
Ford, who several months earlier demonstrated the chan-
ges in the chromosome number and/or structure to be
the cause of Down syndrome. In 1964, the first Centre
for Human Genetics in former Yugoslavia, consisting of
the ward for children suspected to carry some hereditary
burden, genetic counselling unit and cytogenetic labora-
tory, was established at Department of Pediatrics, Zagreb
University Hospital Centre and School of Medicine, Uni-
versity of Zagreb, with financial support from the Associ-
ation for the Aid of Crippled Children from New York,
USA. In 1984, the Centre grew into Department of Hu-
man Genetics, headed by Ljiljana Zergollern until 1991.
In 1993, Department of Human Genetics merged with
Department of Metabolic Diseases, Zagreb University
Hospital Center to become Department of Genetics and
Metabolic Diseases, successfully headed by Professor Da-
vor Begovi}, Professor Ljiljana Zergollern’s disciple. In
2009, this Department was divided into two specialist de-
partments, Department of Medical Genetics and Depart-
ment of Metabolic Diseases.
In 1961, population geneticists Silvije Vuleti}, Davor
Ivankovi} and Josipa Kern from »Andrija [tampar«
School of Public Health joined the small group of human
geneticists, mostly Ljiljana Zergollern’s coworkers. Over
time, this heterogeneous group of experts and scientists
engaged in the field of human genetics increased, being
gradually joined by professionals of various educational
backgrounds, i.e. physicians, biologists, biochemists,
pharmacists, dental medicine doctors, etc. Their work
covered the then few fields of human genetics such as
population genetics, cytogenetics, clinical genetics, an-
thropology, and the beginnings of molecular and bio-
chemical genetics. They all shared the enthusiasm for
work in the field that by its nature demanded and stimu-
lated multidisciplinary collaboration. Their partnership
and associating started in 1972 at the Croatian Medical
Association with foundation of the Section of Human Ge-
netics. As early as 1974, members of the Section of An-
thropology contributed substantially to the recognition
of human genetics. In 1977, the Section grew to the Cro-
atian Society of Anthropology, president Hubert Maver,
now so enthusiastically led by Academician Pavao Ru-
dan. The efforts invested by the Society members re-
sulted in foundation of the Institute of Anthropology in
Zagreb in 1992.
From 1975 onward, scientists from the »Rudjer Bo{-
kovi}« Institute (RBI) joined the Section of Human Ge-
netics. At RBI, biomedical and genetic research started
as early as 1955. From 1968, a group of scientists-theore-
ticians from RBI Department of Biology and Experimen-
tal Medicine, headed by Academician @eljko Trgov~evi}
and Vera Zgaga, PhD, Drago Petranovi}, PhD and Mirja-
na Petranovi}, PhD, contributed to better understanding
of the human genome and the effect of UV rays on DNA
synthesis, damage and repair by their experimental work
on prokaryotic bacteria. Study of programmed cell death
was a field of special interest of these scientists. At the
turn of the 9th and 10th decade of the 20th century, fast de-
velopment of molecular medicine and molecular genetics
was supported by construction of the new centre at RBI,
along with strong advancement in molecular biology;
thus, the former department was divided into two orga-
nizational units, Department of Molecular Medicine and
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Department of Molecular Genetics in 1995. Headed by
now Academician Kre{imir Paveli}, Department of Mo-
lecular Genetics turned to the leading national institu-
tion for basic and applied research as well as for their use
in the field of molecular medicine. The projects of cancer
research, cell biology, immunology, virology, neurophar-
macology, endocrine pathology, etc., and promotion of
molecular technologies and their use in clinical practice
were valuable contribution of the Department to the de-
velopment of clinical genetics in Croatia. In the 1970s,
Department of Tissue Typing, Department of Urology,
Zagreb University Hospital Centre, headed by Academi-
cian Andrija Ka{telan, transplantation immunologist,
joined the work of the geneticists.
Department of Clinical Genetics with Laboratory of
Cytogenetics, headed by Doctor Ivo Liguti} and his co-
-workers Professor Iskra Petkovi} and Professor Lukre-
cija Bre~evi}, was founded at the Zagreb University
Children’s Hospital in 1972.
At the beginning of 1983, Clinical Department of Lab-
oratory Diagnosis, re-established and modernized by
Professor Ana Stavljeni} Rukavina, turned to an un-
avoidable collaborator in the work of the Department of
Human Genetics, Clinical Department of Pediatrics, Zag-
reb University Hospital Center, first through the use of
international achievements in the field of biochemistry,
and later through the Croatian pioneer activities in mo-
lecular diagnosis of the rare monogenic disorders. The
collaboration of now Professors Jadranka Serti}, Ksenija
Fumi} and Renata Zadro with human geneticists from
Paris, mediated by Professor Zergollern, proved invalu-
able for the implementation of cystic fibrosis diagnosis in
Croatia. Establishment of the Laboratory of Immuno-
cytogenetics, led by Sanja Davidovi}, brought substantial
improvement in the use of cytogenetics in chromosomal
analysis of hemoblastosis, which in turn contributed to
development of the expert team of Professor Boris Labar,
who established Clinical Unit of Bone Marrow Trans-
plantation as the first one in East Europe, in 1982.
Since 1991, the Laboratory of Calcified Tissues at the
School of Medicine, University of Zagreb, established and
led by Academician Slobodan Vuki~evi}, has greatly con-
tributed not only to Croatian but also to international
osteology by their pioneer scientific as well as daring
practical work on osteogenic tissue cloning.
In 1993, with establishment of the independent Re-
public of Croatia, the Section of Human Genetics, then
with more than 100 very active members, grew into the
Croatian Society of Human Genetics (CSHG) of the Cro-
atian Medical Association, with Ljiljana Zergollern elec-
ted its first president. Because of the great number of
members and their varied interests, the CSHG was di-
vided into two sections, Section of Medical Genetics, led
by Ivo Liguti}, pediatrician, and Section of Molecular Ge-
netics, led by Academician Kre{imir Paveli}. In 1997,
Professor Ana Stavljeni} Rukavina was elected CSHG
president and Professor Ljiljana Zergollern honorary
president for life. In the same year, the first CSHG
branch office with 37 members was established in Split,
led by Professor Vida ^uli}. In 2013, the CSHG Section
of Cytogenetics and Molecular Karyotyping, led by Leona
Moro`in Pohovski, PhD, was established for harmoniza-
tion of its activities and exchange of experiences in this
dynamic field of human genetics.
In Rijeka, a very active group of geneticists, led by
Professor Miljenko Kapovi}, has assembled at the De-
partment of Biology, School of Medicine, University of
Rijeka, to mention only Professor Bojana Brajenovi} and
Assistant Professor Sa{a Ostoji}, for their outstanding
work and enthusiasm. The work of Damir Letini}, pedia-
trician from Zadar, the research by the late Professor
Igor Medica, pediatrician from Pula, and Dr ^alo’s ge-
netic counseling office from Osijek show that human ge-
netics has expanded all over Croatia. In Split, the Depart-
ment of Forensic Genetics has been established recently,
led by Professor Dragan Primorac and Professor [imun
An|elinovi}. In 2005, Professor Ivo Bari} was elected
CSHG president, and since 2009 CSHG president is Pro-
fessor Ingeborg Bari{i}. Currently, there are around fif-
teen departments dealing with human genetics in Croa-
tia, while CSHG members are active not only in Croatia
but also in many international professional societies all
over European Union (EU).
Since their establishment to the present, the activi-
ties of the CSHG have been numerous and heteroge-
neous. Six symposia held in Zagreb and three interna-
tional summer schools in human genetics held at the
Interuniversity Centre Dubrovnik (interrupted by the
war in Croatia) offered an opportunity for the geneticists
from abroad to be introduced in our and for us to be in-
formed on their achievements in the field of human ge-
netics. The work of our geneticists was recognized by
Ljiljana Zergollern elected vice-president and then presi-
dent of the European Society of Human Genetics (1979–
1982). In 1982, the Conference of European Society of
Human Genetics was held in Dubrovnik, which proved
very successful and well-attended. In 1989, 30th anniver-
sary of the work on human genetics in Croatia was cele-
brated under the auspices of the Academy of Medical Sci-
ences of Croatia, with a rich scientific program. In 1994,
the First Croatian Congress of Human Genetics was held
in Zagreb, with more than 150 participants from Croatia
and abroad. The tradition of human genetics congresses
has been successfully continued to the presence, i.e. to
the last one, Fifth Congress of Human Genetics with In-
ternational Participation, held in 2011 in Bol on the Is-
land of Bra~.
Besides national congresses, a number of interna-
tional congresses were held in Croatia, e.g., 8th Balkan
Congress of Human Genetics in Cavtat 2009, Conference
on Cystic Fibrosis in South-East Europe in Dubrovnik
2010 and 11th International Conference on Osteogenesis
Imperfecta, held in Dubrovnik in 2011 owing to great ef-
forts invested by Professor Darko Anti~evi}. CSHG has
also sponsored the conferences of the International Soci-
ety for Applied Biological Sciences (ISABS), organized
for years by Professor Dragan Primorac. In 2013, CSHG
acted as co-organizer of the 12th European Symposium
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on Congenital Anomalies, held in Zagreb in the organiza-
tion of the European Concerted Action on Congenital
Anomalies and Twins (EUROCAT), one of its founders
being Professor Ivo [vel, whose work was continued by
Doctor Ivo Liguti} and Professor Ingeborg Bari{i} who is
current president of EUROCAT. The last important
CSHG meeting were the 1st Days of Human Genetics,
dedicated to Professor Ljiljana Zergollern-^upak. A class
I postgraduate study of the School of Medicine on the
State-of-the-Art in Medical Genetics was organized in
the frame of this meeting. The lectures held presented
new achievements in Croatia and in the world, with the
aim of expert scientific education of young human genet-
icists.
The publication activity of the Croatian human genet-
icists shows many valuable papers, monographs and
books by a number of authors, articles in Croatian and
international journals, etc. The first university textbook
in human and medical genetics was written by Professor
Ljiljana Zergollern as early as 1977, run through four
printings, entitled »Uvod u humanu genetiku i klini~ku
citogenetiku« (Introduction in Human Genetics and Cli-
nical Cytogenetics), issued by »Sveu~ili{na naklada Li-
ber«2. It was followed by other books and textbooks
penned by Professor Zergollern in collaboration with
many CSHG members3–8.
Formal education in human genetics was initiated as
a subject „Fundamentals of Human Genetics” at the Ed-
ucation-Rehabilitation School, University of Zagreb, as
early as 1969, offering young scientists an opportunity to
acquire MS and PhD degree in the field. This form of ed-
ucation has continued to the present, led by Professor
Ingeborg Bari{i}. In 1972, Professor Ljiljana Zergollern
introduced the four-semester Postgraduate Study in Me-
dical Genetics at the School of Medicine in Zagreb, as the
first in the region. During the 20-year period (1973–
1993), nine generations of students attended the study
covering theoretical, medical, ethical and juridical genet-
ics, with lecturers from Croatia and abroad. These activi-
ties were crowned by about 40 MS theses and a dozen of
doctoral dissertations in the field of human genetics, de-
fended at the University of Zagreb. The subject of oro-
facial genetics was introduced as early as 1981, thanks to
the then young dental doctor, now Professor Ilija [krinja-
ri}, first in postgraduate education and since 1983 in un-
dergraduate education at the School of Dental Medicine
in Zagreb, and later also in Rijeka. This greatly improved
education and knowledge of the role of human genetics
in modern dental medicine. Organization of the study in
forensics at the University of Split as the first one in the
region should be noted. Lectures on the subject of Funda-
mentals of Human and Population Genetics, led by Pro-
fessor Ingeborg Bari{i} at the School of Pharmacy and
Biochemistry in Zagreb started in 2007, and since 2010
Medical Genetics is a regular study subject at all medical
schools in Croatia. In Zagreb, the subject is led by Profes-
sors Florijana Buli} Jaku{ and Ingeborg Bari{i}.
Development of Cytogenetics in Croatia
Cytogenetics is the first human genetics subspecialty
developed from cytology and genetics as a branch of med-
icine investigating chromosome number, structure and
dynamics during the cell cycle and division. The discov-
ery that man has 46 chromosomes, made by Tjio and
Levan in 1956, was the turning point at which the study
of human chromosome began. In 1960, a group of cytoge-
neticists from Denver, USA, issued basic guidelines on
chromosome terminology and arrangement. A break-
through occurred at the beginning of the 1970s with the
introduction of banding techniques for chromosome
identification by their unique band arrangement, so that
each chromosome is allocated its place and particular
number in the karyotype. Bands have enabled detection
of numerous structural changes on chromosomes (inser-
tions, inversions, duplication, deletions and transloca-
tions) that could not be observed before.
Always trying to keeping up with international achie-
vements, we made the first karyotype in a child with
Down syndrome, then also in a child with Turner syn-
drome using camera obscura instead of a photomicrosco-
pe, borrowed centrifuge and improvised thermostat in
Zagreb in October 1959, only several months after Le-
jeune (Montreal–Paris, 1958) and Ford (Oxford, 1959).
Since then, cytogenetics has been progressing rapidly in
our setting, pointing to the association of chromosome
aberrations not only with various syndromes in human
pathology, but also with carcinogenesis, monogenic disor-
ders, alterations caused by viral diseases, and lesions in-
duced by x-ray and other harmful factors. Besides De-
partment of Human Genetics, Department of Pediatrics,
Zagreb University Hospital Centre, organized work in
the field of cytogenetics has also been introduced in other
institutions in Zagreb, and then all over Croatia. At De-
partment of Gynaecology and Obstetrics, »Merkur« Uni-
versity Hospital in Zagreb, the work in cytogenetics was
started by Professor Zvonimir Singer and biologist Mirko
Beck in 1963; in Zagreb University Children’s Hospital
by Head Doctor Ivo Liguti} and Professor Iskra Petkovi}
in 1971; and in »Sestre milosrdnice« University Hospital
Center by paediatrician Ljerka Schmutzer and dental
medicine doctor Goran Horgas in 1972. In 1992, at the
request by Professor Asim Kurjak, gynecologist, Profes-
sor Ljiljana Zergollern with Feodora Stipoljev, biologist,
established Cytogenetic Laboratory with Genetic Coun-
selling Unit at »Sveti Duh« University Hospital. At De-
partment of Biology, University of Rijeka, biologists Vera
Toma{i}, Milica Kru`i} and Stjepan Urban, with the help
of cytogeneticists from Zagreb started pioneer work in
the fields of cytogenetics and population genetics in the
Primorje area. Later on, cytogenetic laboratories were
also organized in Split and Osijek.
The advent of the methods of molecular cytogenetics
such as fluorescent in situ hybridization (FISH) in the
1980s made a new breakthrough, followed by the meth-
ods of Multiplex Ligation-dependent Probe Amplification
(MLPA) and chromosomal microarray analysis (CMA) at
the beginning of the 21st century. After professional
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training in The Netherlands, biologist Ru`ica Lasan-
-Tr~i} was the first to introduce FISH method in routine
practice at the Zagreb University Hospital Center in
19969. At Department of Clinical Genetics, Zagreb Uni-
versity Children’s Hospital, Professor Iskra Petkovi} was
the first to use FISH technique in addition to classic
FISH diagnosis in screening for chromosome subtelo-
meric regions in 200110. Then, FISH diagnosis was soon
introduced in other institutions in Croatia. At Zagreb
University Children’s Hospital, Leona Moro`in Pohov-
ski, PhD, and Ivona Sansovi}, PhD, introduced MLPA in
the diagnosis of microdeletions/duplications, subtelome-
ric aberrations, frequent mutations and major deletions
in more common monogenic disorders11,12.
As novel methods of molecular karyotyping, such as
genome microarray and next generation sequencing ha-
ve been introduced in clinical practice, they are expected
to be included in the clinical routine also in Croatia in
the near future.
Development of Prenatal Diagnosis
in Croatia
Following the respective events worldwide, prenatal
diagnosis was very early introduced in Croatia as well.
Professors Milan Buli} and Jovan Vuji} from »Merkur«
University Hospital were the first to employ ultrasound
in morphological fetus analysis in 1969. The team con-
sisting of Buli} and Vuji} (amniocentesis), Singer and
Beck (amniotic fluid cell culture and fetal karyotype
analysis) and Zergollern (genetic counselling) started
working in spring 1969, along with the pioneer work on
the prenatal diagnosis of chromosomal disorders by cul-
ture and cytogenetic testing of amniotic fluid cells. The
first amniocentesis performed in the 16th week of gesta-
tion, was just the first step of this team’s ’pilot study’,
approved as a routine method only in 1971. In Croatia,
the first child undergoing amniocentesis and cytogenetic
chromosome analysis was born in February 1972 as the
first such child in the former Yugoslavia, where Zagreb
was the only center developing »aggressive prenatal di-
agnosis«. Professor Vuji} was brave enough to perform a
number of fetoscopy procedures; however, he soon aban-
doned this diagnostic technology due to the high risk for
the fetus. In 1974, Professor Zvonimir Singer started
performing placentocentesis, later joined by Marjan Po-
dobnik, using the tissue obtained for both cytogenetic
and molecular analysis, and for determination of the pla-
cental condition and maturity. In the same year, the team
from the Department of Gynecology and Obstetrics, Zag-
reb University Hospital Centre (V. Latin, A. Kurjak and
B. Rajhvajn Jr.) introduced amniocentesis in their rou-
tine and established long-term collaboration with De-
partment of Human Genetics, Zagreb University Hospi-
tal Centre, where cell culture and karyotype analysis was
taken over by Dubravka Mu`ini}, competent disciple and
collaborator of Professor Lj. Zergollern, with a group of
laboratory technicians. Other centers have also been es-
tablished elsewhere. In 1986, Department of Biology,
Rijeka School of Medicine, introduced amniotic fluid cell
culture. A team of cytogeneticists led by Professor Boja-
na Brajenovi}-Mili} were the first in Croatia to introduce
prenatal screening for Down syndrome in maternal blood
in 199613. In 1992, cytogenetic laboratory was estab-
lished at »Sveti Duh« University Hospital, with great
help offered by Professor Zergollern, where all tech-
niques of prenatal diagnosis have been introduced to
date. Assist. Professor Feodora Stipoljev with the help of
her laboratory staff introduced analysis of chorionic vil-
lus biopsy, currently available only at their institution in
Croatia14. The cytogenetic laboratory led by Professor
Vida ^uli} started performing amniotic fluid culture and
analysis in 2007. In 2001, Kristina Crikvenac-Gornik, bi-
ologist, developed a method of microsatellite loci for the
diagnosis of most common aneuploidies and analysis of
STR loci for the diagnosis of uniparental disomy15. Ja-
senka Wagner from Osijek introduced fetal sex determi-
nation from maternal blood in 200816. Development of
biochemical methods and molecular diagnosis techni-
ques enabled introduction of the prenatal diagnosis of
monogenic disorders such as cystic fibrosis, fragile X syn-
drome or spinal muscular atrophy in Croatia; however,
assistance of the respective laboratories from abroad is
still required in case of rare hereditary disorders.
Development of Molecular Diagnosis
in Croatia
In Croatia, the use of molecular diagnosis in clinical
practice dates back to the 1990s with the molecular diag-
nosis of cystic fibrosis17,18. Since then, genetic assays for
many monogenic and multifactorial disorders have been
developed at Clinical Laboratory of Molecular Diagnosis,
Zagreb University Hospital Center. The diagnosis of met-
abolic disorders has been developing at the Clinical Labo-
ratory of Hereditary Metabolic Diseases, headed by Pro-
fessor Ksenija Fumi}. Department of Functional Geno-
mics was established in 2003, supported by the Ministry
of Science, Education and Sports, as a joint project of the
School of Medicine, University of Zagreb and Zagreb
University Hospital Centre. Until 2005, Department was
headed by Professor Dmitrij Krainc. Later, Department
grew into Department of Translational and Clinical Re-
search, headed by Professor Fran Borove~ki. In the 1990s,
diagnosis of genetic disorders was also introduced at the
RBI Department of Molecular Biology headed by Acade-
mician Kre{imir Paveli}, then by Professor Jasminka
Paveli}19–22. Currently, a number of projects have been
carried out at the Department, led by Oliver Vugrek, in-
cluding development of molecular target cancer and viral
disease therapy, development of new diagnostic tools and
studies aiming at decoding the molecular basis of dis-
eases, and at development of tools based on omics ap-
proach. During the war in Croatia, Professor Dragan
Primorac in collaboration with a group of scientists from
Split led by Professor [imun An|elinovi} worked on the
identification of Patriotic War victims and set fundamen-
tals for the development of modern forensics in Croa-
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tia23. Molecular diagnosis of monogenic and multifacto-
rial disorders has been developed at Zagreb University
Children’s Hospital24,25, and of tumors in Split (diagnosis
of leukemias and lymphomas).
Genomics, Pharmacogenomics
and Personalized Medicine
New technologies for genome analysis have led to the
development of genomics, a scientific discipline investi-
gating the structure, organization and functioning of the
genome. The field of genomics also includes the study of
intragenomic phenomena such as epistasis, pleiotropy
and other interactions between gene loci, and in broader
sense the research not only at the DNA level (genotype)
but also at the level of mRNA (transcriptomics) and pro-
teins (proteomics).
Whole genome studies, and exome and RNA sequenc-
ing have dramatically increased the number of known so-
matic alterations, i.e. mutations, amplifications, dele-
tions and translocations associated with tumors develop-
ment. Molecular information can be used for developing
target therapy for particular patient subgroups, as well
as for monitoring therapeutic efficacy and prognosis of
disease aggressiveness, thus avoiding unnecessary and
expensive procedures in patients not expected to respond
to therapy26. Progress in this field of genetics is expected
to be achieved at the RBI Department of Molecular Medi-
cine by use of the new methodologies through multi-
disciplinary collaboration of molecular biologists, chem-
ists, biomedical experts and bioinformatics professionals,
which may hopefully result in the development of novel
anti-tumor agents.
Some ten thousand monogenic disorders have been
identified to date, most of them very rare, however, yet
involving millions of people all over the world. These new
technologies enable us to identify a hundreds of genes re-
sponsible for the occurrence of etiologically heteroge-
neous entities such as epilepsy, autism or intellectual dis-
abilities, as well as gene mutations responsible for the
occurrence of rare and poorly known diseases27. In Croa-
tia, groups of scientists are also engaged in a number of
multicenter studies investigating the complex genetic ba-
sis of multifactorial disorders, to mention only Professor
Gordan Lauc and his co-workers in Genos, scientists
from the Institute of Anthropology and Croatian Centre
for Global Health, until recently led by Professor Igor
Rudan28,29.
Clinically relevant examples of the impact of genetics
on drug metabolism have already been known for de-
cades and belong to the field of pharmacogenetics. In
Croatia, this field has been very successfully dealt with
by Professor Nada Bo`ina, head of the Clinical Labora-
tory of Pharmacogenomics and Individualized Therapy,
Department of Laboratory Diagnosis, Zagreb University
Hospital Center30. This discipline has recently evolved to
pharmacogenomics, a discipline studying the role of he-
reditary and acquired genome variations in the patient
response to the drug administered. Genome sequencing
can identify variations influencing individual metabo-
lism, thus also drug response; based on this information,
drug type, dosage and therapy duration can be chosen,
avoiding the possible side effects. In the future, it is ex-
pected that we will choose the type and dosage of drugs
individually for each patient rather than matching it to
the average obtained by clinical trials. In addition, so-
phisticated instruments can rapidly identify and analyse
genetic structure of microorganisms, i.e. viruses and bac-
teria (microbiomics), which will facilitate the search for
new drugs against the pathogens undergoing mutation
and developing resistance. Quite intriguing is also the
new field of metagenomics that investigates the interac-
tion between the host genome and the microorganisms,
aiming to facilitate understanding of complex diseases
such as inflammatory ones.
The concept of personalized medicine, i.e. the use of
the individual’s genetic composition to predict the risk of
disease development and its course, and to adjust the
treatment protocol according to the unique patient re-
quirements, has been known for more than hundred
years now. However, it was the introduction of high-reso-
lution technology in genome analysis that brought revo-
lutionary progress in the field of personalized medicine.
Along with progress in computer biotechnology, these
technologies enabled simultaneous analysis of thousands
of molecules in the genome and interpretation of large
groups of data obtained in these experiments. The intro-
duction of target therapy has increased the need of de-
tailed molecular characterization of the disease and iden-
tification of biomarkers for the prognosis and prediction
of therapeutic success and disease outcome31. At the RBI,
this topic is especially tackled at the Laboratory of Per-
sonalized Medicine, led by Professor Sanja Kapitanovi}.
The scientific activities of this laboratory are focused on
the study of the molecular-genetic basis of the occur-
rence and progression of sporadic tumors of the colon
and on the pharmacogenetic studies of the efficacy or
toxicity of anti-tumor therapy.
In the past decade, the interest in the field of epigene-
tics has increased considerably. Epigenetics is a discipline
investigating hereditary alterations in gene expression
that cannot be ascribed to DNA sequence changes. The
main epigenetic mechanisms include DNA methylation,
modification of chromatin structure, loss of imprinting,
and noncoding RNA. An important characteristic of the-
se mechanisms is that they can be inherited via meiotic
and mitotic division, while being capable of being deleted
later during cell differentiation or upon exposure to
extracellular and environmental factors. Epigenomics is
a science investigating the genome epigenetic marks and
their effect on the global gene expression and trying to
explain why the cells and organisms with identical DNA
can have so dramatically different phenotypes. Just as
variations in DNA sequence (previously called muta-
tions) can contribute to development of disease, epigene-
tic changes such as impaired DNA methylation or histo-
ne modification can favor development of multifactorial
diseases (e.g., cardiovascular disease, hypertension, dia-
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betes mellitus, some infectious diseases) and neoplasms
(e.g., leukemia, lymphomas, sarcoma, and carcinoma of
the breast, lung, prostate, liver and colon). Recently, a
great body of data has been acquired on the epigenetic
mechanisms and involvement of epigenetic regulation of
gene expression as the underlying pathogenic mecha-
nism in the development of other phenotypes and dis-
eases such as mental disorders, autism and epilepsy. Di-
etary habits and other external factors can alter epigene-
tic regulation, which explains the association between
the lifestyle and the risk of disease development observed
by the scientists. Epigenetic marks (DNA methylation,
mRNA and microRNA expression, etc.) can serve as
biomarkers for risk stratification, early detection and
classification of diseases, and also as the targets for treat-
ment and chemoprevention, thus promising development
of novel therapeutic strategies.
In spite of all difficulties, we certainly enter a new
revolutionary era of personalized medicine. Currently,
we can collect considerably more data than we can inter-
pret. The data of electronic medical records, genomics,
epigenetics, transcriptomics, proteomics, metabolomics
and microbiomics should be integrated and interpreted.
Therefore, when speaking about the impact of genomics
on the health and disease, sequencing of individual ge-
nomes of healthy persons (integrative personal omics
profiling, iPOP) integrating data on all »omics«, i.e.
transcriptome, metabolome and proteome into the per-
sonal omics profile to be observed in health and disease is
of utmost importance32. Although quite promising, it
may be perceived as a favorable circumstance that these
methods are still too expensive for routine use in medical
practice. Their wide use will certainly open an array of
ethical questions we have to be ready to face on time.
These include questions of data availability, in particular
to family members that might carry the same risk as the
proband, but also related to wider community (employer,
insurance companies, healthcare system and legal sys-
tem). Accidental findings pose a special practical chal-
lenge. Is it necessary to inform the patient only on the re-
sults related to the disease for which he/she has under-
gone testing or on all his/her genome findings? Should
the patient be informed on the variants associated with
the risk of developing a disease for which there is no cure
or preventive methods? How to ensure confidentiality of
such a huge amount of data? How to regulate genetic
testing which is commercially available on the market
without appropriate genetic information? In the years to
come, we can expect to learn more about genetics than
we have learned throughout the history of medicine, and
we should be properly prepared for it, considering seri-
ously all the favorable as well as unfavorable aspects of
modern achievements in the field of genetics33.
Genetic Counselling
In 1975, the American Society of Human Genetics
adopted the probably best known and most widely ac-
cepted definition of genetic counselling to date, stating
that it is a communication process that deals with the
human problems related to the occurrence or risk of oc-
currence of a genetic disorder in a family. It includes one
or more competent professionals trying to help an indi-
vidual or a family to (a) comprehend medical facts includ-
ing diagnosis, probable course of disease and treatment
options; (b) understand the way in which heredity influ-
ences disease development and risk of disease recurrence
in a family; (c) comprehend all the options available con-
sidering the risk involved; (d) use genetic information in
a reasonable way in order to promote health, reduce psy-
chological stress and upgrade personal control; (e) choose
the mode of action he/she finds appropriate according to
the risk involved, family planning and ethical issues, and
to act in line with his/her own decision; and (f) achieve
the best possible adjustment to the disease affecting the
family and to the implied risk of disease recurrence34.
The first genetic counselling unit in Croatia was estab-
lished by Professor Zergollern in 1964 at Department of
Human Genetics, Department of Pediatrics, Zagreb Uni-
versity Hospital Centre, which was followed by the ge-
netic counselling units in Zagreb University Children’s
Hospital in 1972, and then also in Split and Osijek. Ge-
netic counselling should be as a rule administered by a
properly trained professionals. In Croatia, respective ed-
ucation is acquired through residency in pediatrics, sub-
-residency in medical genetics. In special cases, other
specialists can be trained in particular issues (for exam-
ple, gynecologist for prenatal screening of older pregnant
women or oncologist for particular tumor types), which
requires specific education and accreditation issued by
the Croatian Society of Human Genetics, Croatian Medi-
cal Association35. Fast development of the knowledge and
understanding the molecular basis of genetic disorders
has opened new diagnostic options such as prenatal,
pre-symptomatic and predictive genetic testing, determi-
nation of carrier status for genetic disorders, and even
detection of hereditary disorders through various screen-
ing programs for risk groups or the population at large.
These complex procedures require thorough information
on all medical facts. Therefore, genetic counselling
should be an integral part of genetic testing, but must
not be coercive. Based on quality information, each per-
son makes his/her own decision independently, which
he/she considers best for him/her and his/her family.
Maximum privacy and confidentiality should be ensured
for both the information communicated by the person
and the information obtained by genetic testing. On ge-
netic counselling, the whole family should be provided
with any psychological and moral support required in the
context of their family values and beliefs, family relation-
ships, and in particular their cultural and social environ-
ment36,37.
The Future of Human Genetics in Croatia
Until now, we have been able to follow the develop-
ments of human genetics in the world with our technical
and other economic resources; however, this develop-
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ment is so fast that we frequently have to give up, won-
dering whether we can ensure a satisfactory develop-
ment of clinical genetics disciplines in the forthcoming
years. Considering the progress of our science that has
succeeded in keeping pace with the globalization trends
to date, we do hope that our society members working at
various institutes, departments and laboratories will
continue working in the field of human genetics accord-
ing to the bioethical principles, applying their results in
the diagnosis and therapy of neoplastic, chromosomal,
gene and other diseases associated with genome changes.
Although ethics and jurisdiction with legislation are
outrun by the too fast technologic and genetic achieve-
ments, they have been integrated in the CSHG activities,
so that jurists, philosophers and theologians took active
part as invited lecturers at CSHG conventions and sym-
posia since as early as 1974. In 1995, the newly founded
Croatian Society of Bioethicists with Van Potter and Pro-
fessor [egota as active founders supported the geneti-
cists’ efforts to halt the general drop in morality and eth-
ics, visible in many aspects of the modern society, even in
biomedical and biologic sciences, which can have unpre-
dictable consequences for the humanity. In this tumultu-
ous time of the rule of biotechnology, homo sapiens
should stay homo sapiens and find the right way to pre-
serve life and health of all living creatures, primarily
man, while not arresting the progress of biomedical and
technologic sciences. Not everything that is possible in
science is acceptable or ethical. According to Bishop
Valentin Pozai}, technology has no conscience, but a sci-
entist should have it. Just think how good intended were
the scientists that discovered powder, atomic and nuclear
energy, antibiotics, etc. Instead of proper use, the wrong
and conscience uncontrolled employment of these discov-
eries led and is still leading to its mere contrast causing
numerous tragedies. Apart from the positive effects of
such discoveries, favorable for the humankind, today’s
conscientious scientists, philosophers and writers such
as Hawking, Fukuyama or Rifkin are particularly wor-
ried by the biotechnology with genetic engineering. Rot-
blat, atomic physicist and 1995 Nobel Prize Winner, is
afraid of mankind destruction by genetic engineering
rather than atomic energy. Is it possible that the expen-
sive biotechnology, modifying bioevolution into biorevo-
lution by its over-dynamic behavior, would eventually
lead to chaos through which nature will not be main-
tained but destroyed?
Genetic engineering has contributed and continues
contributing to human welfare by the results of the work
of many scientists including human geneticists. Drugs,
multivalent oral vaccines and vaccines against certain
malignancies, cloning of tissue cells and organs for exper-
imental or therapeutic use in homo-, hetero- and xeno-
transplantation, transgenic animals, in vitro fertiliza-
tion, preimplantation and presymptomatic diagnosis of
some diseases, gene therapy, stem cell experiments and
therapy, achievements in genomics, proteomics and onco-
genomics, and the supreme success in the cloning of
mammals, even primates, and perhaps man somewhere
in secret, make the future of human genetics. Technically,
we are not far from the possibility, already practiced in the
USA, to create children with particular characteristics,
and to substitute the hateful racial discrimination by the
genetic one. All this is currently part of the work of the
Croatian geneticists as well. As according to Pope John
Paul II, the omnipotent, rich industry has, like mer-
chants, entered the temple of science, we should be wor-
ried whether, in the times of deep economic and even
deeper moral crisis, there are some among us who are
ready to put their personal profit ahead of moral postu-
lates. However, although Pandora’s box has long been
wide open, there is still hope that the development of
top-line genetics, and thus of biomedical science will pre-
vent it before entering the programmed computer intelli-
gence (Hawking) and prior to our post-human future
(Fukuyama), when the new, through eugenetic game af-
fluent genetically improved people will threaten those
unimproved, poor, occasionally born with congenital ano-
malies. Genetic lottery with nature can be considered un-
just individually, but is fully egalitarian because it does
not endanger human nature, human dignity and rights
and because it may involve anybody irrespective of the
class and nationality. Although we would like to be opti-
mistic, we do share the worries of some scientists-medi-
cal technologists, who do not see only good results in the
progress of science, but look at it with skepticism, in fear
from the far-reaching consequences of these achieve-
ments for human race because they feel that some scien-
tists of today substitute revolution for evolution in na-
ture, playing God38 and claiming right to modify nature
in a fast and revolutionary manner. The capacity of hu-
man imagination is immeasurable and more valuable
than the knowledge acquired. Science fiction has the fea-
ture of coming true, while the works once perceived as
fanciful not infrequently are realized as visionary achie-
vements. Until recently, organ transplantation seemed
impossible, inhuman and impermissible, while nowadays
we speak of organ and organism cloning, gene and organ
chips, genetic identity cards, etc.
What is the »tomorrow« of human genetics in Croa-
tia? We believe that the community of experts dealing
with human genetics in Croatia will grow further and
that they will, in spite of the current financial restric-
tions, have an opportunity to develop both practical use
in the diagnosis, treatment and prevention of hereditary
disorders and the basic genetic research that will expand
our horizon and understanding of the concept of health
and disease. We do hope that it will be done within the
modern model of integrating bioethics which takes in
consideration the standpoints of all relevant scientific
disciplines, as well as the broader cultural perspective,
and discuss more broadly the role of genetic science in
modern civilization.
Acknowledgements
Thanks to all contributors for their generous efforts
to help us recollect details on the development of differ-
Lj. Zergollern-^upak et al.: Development of Genetics in the World and in Croatia, Coll. Antropol. 38 (2014) 3: 809–818
816
ent genetic disciplines in Croatia. We also thank all the
experts, clinicians and scientists who have contributed to
the development of human genetics in Croatia, and we
apologize if we inadvertently have omitted someone.
R E F E R E N C E S
1. WATSON JD, CRICK FHC, Nature, 171 (1953) 737. — 2. ZERGO-
LLERN-^UPAK LJ, Uvod u medicinsku genetiku s klini~kom citogeneti-
kom (Sveu~ili{na naklada Liber, Zagreb, 1977). — 3. ZERGOLLERN-
-^UPAK LJ, Uvod u medicinsku genetiku s klini~kom genetikom (Sveu~i-
li{na naklada Liber, Zagreb, 1980). — 4. ZERGOLLERN LJ, KURJAK A,
Prenatalna dijagnostika (JUMENA, Zagreb, 1984). — 5. ZERGOLLERN
LJ, Medicinska genetika 1, 2nd ed. ([kolska knjiga Zagreb, 1991). — 6.
ZERGOLLERN LJ, Medicinska genetika 2 ([kolska knjiga Zagreb, 1994).
— 7. ZERGOLLERN LJ, Humana genetika, 3rd ed. (Medicinska naklada,
Zagreb, 1994). — 8. ZERGOLLERN LJ, Pedijatrija 1 i 2 (Naprijed, Zag-
reb, 1994). — 9. LASAN-TRCI] R, HITREC V, LETICA LJ, ]UK M,
BEGOVI] D, Croatian Medical Journal, 44 (2003) 477. — 10. PETKOVI]
I, BARI{I] I, Paediatr Croat, 47 (2003) 1. — 11. MOROZIN POHOVSKI
L, DUMI] K, ODAK LJ, BARI[I] I, Mol Cytogenet, 6 (2013) 7. DOI: 10.
1186/1755-8166-6-7. — 12. SANSOVI] I, BARI[I] I, DUMI] K, Biochem
Genet, 51 (2013) 189. DOI: 10.1007/ s10528-012-9554-9. — 13. BRAJE-
NOVI]-MILI] B, TISLARI] D, BACI] J, PARAVI] J, SLIVAR AE,
KAPOVI] M, KO[E] V, RISTI] S, RAJHVAJN B, Fetal Diagn Ther, 13
(1998) 367. — 14. VI^I] A, STIPOLJEV F, Paediatr Croat, 57 (2013) 392.
DOI: 10.13112/PC.2013.12. — 15. CRKVENAC-GORNIK K, GRUBI] Z,
STINGL K, MU@INI] D, BRKLJA^I]-KERHIN V, BEGOVI] D, Coll
Antropol, 31 (2007) 859. — 16. WAGNER J, DZIJAN S, PAVAN-JUKI] D,
WAGNER J, LAUC G, Prenat Diagn, 28 (2008) 412. DOI: 10.1002/pd.
1986. — 17. ZERGOLLERN LJ, STAVLJENI]-RUKAVINA A, BARI[I]
I, SERTI] J, Acta Med Croat, 46 (1992) 181. — 18. ZERGOLLERN LJ,
STAVLJENI]-RUKAVINA A, BARI[I] I, SERTI] J, Period Biol, 95
(1993) 359. — 19. HE]IMOVI] S, BARI[I] I, PETKOVI] I, BARI] I,
LIGUTI] I, PAVELI] K, Clin Genet, 52 (1997) 147. — 20. TANACKO-
VI] G, BARI[I] I, GJERGJA-MATEJI] R, HE]IMOVI] S, PAVELI] J,
Clin Genet, 58 (2000) 333. — 21. PAVELI] J, KRIZANAC S, KAPITA-
NOVI] S, PAVELI] L, SAMARZIJA M, PAVICI] F, SPAVENTI S, JA-
KOPOVI] M, HERCEG-IVANOVI Z, PAVELI] K, Am J Respir Cell Mol
Biol, 32 (2005) 65. — 22. MATIJEVI] T, KNEZEVI] J, BARI[I] I, RE-
SI] B, CULI] V, PAVELI] J, Ann N Y Acad Sci, 1091 (2006) 225. — 23.
MARJANOVI] D, KONJHODZI] R, BUTORAC SS, DROBNIC K, MER-
KAS S, LAUC G, PRIMORAC D, ANDJELINOVI] S, MILOSAVLJEVI]
M, KARAN Z, VIDOVI] S, STOJKOVI] O, PANI] B, VUCETI] DRA-
GOVI] A, KOVA^EVI] S, JAKOVSKI Z, ASPLEN C, PRIMORAC D,
Croat Med J, 52 (2011) 235. — 24. SANSOVI] I, KNE@EVI] J, MUSANI
V, SEEMAN P, BARI[I] I, PAVELI] J, Genet Test Mol Biomarkers, 13
(2009) 693. DOI: 10.1089/gtmb.2009.0073. — 25. SANSOVI] I, DUMI]
KUBAT K, BARI[I] I, Paediatr Croat, 57 (2013) 408. DOI: 10.13112/PC.
2013.14. — 26. ULAHANNAN D, KOVAC MB, MULHOLLAND PJ, CA-
ZIER JB, TOMLINSON I, Chem Biol, 20 (2013) 660. DOI: 10.1016/j.
chembiol.2013.05.001 — 27. SOON WW, HARIHARAN M, SNYDER MP,
Mol Syst Biol, 9 (2013) 640. DOI: 10.1038/msb.2012.61. — 28. KRISTIC J,
VUCKOVIC F, MENNI C, KLARIC L, KESER T, BECEHELI I, PUCIC-
-BAKOVIC M, NOVOKMET M, MANGINO M, THAQI K, RUDAN P,
NOVOKMET N, SARAC J, MISSONI S, KOLCIC I, POLASEK O, RU-
DAN I, CAMPBELL H, HAYWARD C, AULCHENKO Y, VALDES A,
WILSON JF, GORNIK O, PRIMORAC D, ZOLDOS V, SPECTOR T,
LAUC G, J Gerontol A Biol Sci Med Sci, 69 (2014) 779. DOI: 10. 1093/
gerona/glt190. — 29. LAUC G, HUFFMAN JE, PU^I] M, ZGAGA L,
ADAMCZYK B, MU@INI] A, NOVOKMET M, POLA[EK O, GORNIK O,
KRI[TI] J, KESER T, VITART V, SCHEIJEN B, UH HW, MOLOKHIA
M, PATRICK AL, MCKEIGUE P, KOL^I] I, LUKI] IK, SWANN O, VAN
LEEUWEN FN, RUHAAK LR, HOUWING-DUISTERMAAT JJ, SLAG-
BOOM PE, BEEKMAN M, DE CRAEN AJ, DEELDER AM, ZENG Q,
WANG W, HASTIE ND, GYLLENSTEN U, WILSON JF, WUHRER M,
WRIGHT AF, RUDD PM, HAYWARD C, AULCHENKO Y, CAMPBELL
H, RUDAN I, PLoS Genet, 9 (2013) e1003225. DOI: 10.1371/journal.
pgen.1003225. — 30. BO@INA N, PEJNOVI] L, Paed Croat, 57 (2013)
336. DOI: 10.13112/PC.2013.4. — 31. HUDSON TJ, J Intern Med, 274
(2013) 440. DOI: 10.1111/joim.12097. — 32. LI-POOK-THAN J, SNYDER
M, Chem Biol, 20 (2013) 660. doi: 10.1016/j.chembiol.2013.05.001. — 33.
YIM SH, CHUNG YJ, 11 (2013) 218. DOI:10.5808/GI.2013.11.4.218. —
34. FRAZER FC, Am J Hum Genet 26 (1974) 636. — 35. BARI[I] I, Pae-
diatr Croat, 54 (2010) 213. — 36. MCCONKIE-ROSELL A, SPIRIDI-
GLIOZZI GA, J Genet Couns, 13 (2004) 9. — 37. BARI[I] I, Eti~ki
aspekti geneti~kog testiranja u djece In: ^OVI] A, RADONI] M (Eds)
Bioetika i dijete (Pergamena, Zagreb, 2011). — 38. MATULI] T, Nevjera i
vjera – u ~etiri oka, (Glas Koncila, Zagreb 2012).
L. Moro`in Pohovski
University of Zagreb, School of Medicine, Children’s Hospital Zagreb, Klai}eva 16, 10000 Zagreb, Croatia
e-mail: leona.more@yahoo.com
RAZVOJ GENETIKE U SVIJETU I U HRVATSKOJ – POVODOM 40 GODINA HRVATSKOGA
DRU[TVA ZA HUMANU GENETIKU HRVATSKOGA LIJE^NI^KOG ZBORA
S A @ E T A K
Nastala iz vi{e bazi~nih znanstvenih disciplina, genetika je do`ivjela izvanredan napredak u pro{lom stolje}u otkri-
}ima pravila naslje|ivanja, osnove gra|e genoma i identifikacijom gena koji odre|uju nastanak osobina i bolesti ~ovje-
ka. U Hrvatskoj je razvoj genetike zapo~eo sredinom pro{loga stolje}a pionirskim radom klini~ara i bazi~nih znanstve-
nika, {to je rezultiralo zna~ajnim razvojem ove znanstvene discipline koja je brzo na{la svoju prakti~nu primjenu u
klini~koj genetici-citogenetici, molekularnoj genetici i prenatalnoj dijagnostici. Brz napredak tehnologije i znanja o ge-
netici u posljednjim desetlje}ima doveo je do razvoja genomike i srodnih disciplina pa se mo`e re}i da smo u{li u novu
revolucinarnu eru personalizirane medicine. Danas mo`emo prikupiti puno vi{e podataka nego {to ih mo`emo protu-
ma~iti. Podatke elektroni~kih medicinskih zapisa, genomike, epigenetike, transkriptomike, proteomike, metabolomike,
mikrobiomike treba integrirati i interpretirati na razini genoma pojedinca.[iroka uporaba novih informacija otvorit }e
niz eti~kih pitanja s kojima se moramo na vrijeme suo~iti. O~ekuje se da }emo u idu}im godinama mo}i nau~iti o gene-
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tici vi{e no {to smo nau~ili u cijeloj povijesti medicine, a to moramo do~ekati spremni, promi{ljaju}i sve pozitivne, ali i
negativne aspekte suvremenih dostignu}a u podru~ju genetike. Nadamo se da }e stru~njaci koji se bave humanom
genetikom u Hrvatskoj nastaviti uspje{no sa svojim radom koji }e omogu}iti prakti~nu primjenu suvremenih dostignu-
}a u genetici te pro{iriti na{e razumijevanje koncepta bolesti i zdravlja.
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